AMITRIPTYLINE HYDROCHLORIDE

AMITRIPTYLINE HYDROCHLORIDE was reported 18062 times

These side effects are most commonly reported by patients taking AMITRIPTYLINE HYDROCHLORIDE:

# Side effect Count
0 PAIN 1684
1 NAUSEA 1576
2 HEADACHE 1509
3 FATIGUE 1480
4 DYSPNOEA 1468
5 DIZZINESS 1260
6 DIARRHOEA 1220
7 MALAISE 1108
8 VOMITING 1081
9 FALL 1078
10 OFF LABEL USE 1070
11 ARTHRALGIA 1009
12 COGNITIVE DISORDER 961
13 DRUG INEFFECTIVE 917
14 PRURITUS 876
15 ANXIETY 869
16 INSOMNIA 834
17 PYREXIA 829
18 CONSTIPATION 800
19 HYPOTENSION 795
20 BACK PAIN 771
21 CHEST PAIN 751
22 TOXICITY TO VARIOUS AGENTS 739
23 FEELING ABNORMAL 731
24 INFUSION SITE PAIN 730
25 HYPERHIDROSIS 714
26 MIGRAINE 701
27 RASH 690
28 PERIPHERAL SWELLING 688
29 PALPITATIONS 642
30 ABDOMINAL PAIN UPPER 637
31 BALANCE DISORDER 633
32 VISUAL IMPAIRMENT 622
33 COVID-19 604
34 TACHYCARDIA 592
35 ABDOMINAL DISCOMFORT 584
36 MYOCARDIAL INFARCTION 582
37 PAIN IN EXTREMITY 580
38 HALLUCINATION 574
39 MEMORY IMPAIRMENT 569
40 MUSCULAR WEAKNESS 555
41 HEART RATE INCREASED 542
42 SEDATION 538
43 DRUG INTERACTION 536
44 DEPRESSED LEVEL OF CONSCIOUSNESS 529
45 MOBILITY DECREASED 525
46 LIP SWELLING 522
47 ORTHOSTATIC HYPOTENSION 517
48 DISTURBANCE IN ATTENTION 515
49 DEHYDRATION 511
50 TINNITUS 502
51 ALOPECIA 487
52 ANGIOEDEMA 483
53 AMNESIA 479
54 ASTHENIA 477
55 INTENTIONAL PRODUCT MISUSE 476
56 BLOOD GLUCOSE INCREASED 469
57 DEPRESSION 468
58 PNEUMONIA 467
59 SOMNOLENCE 461
60 INFUSION SITE ERYTHEMA 455
61 DRY SKIN 452
62 BLOOD CALCIUM DECREASED 440
63 TRANSIENT ISCHAEMIC ATTACK 439
64 CONFUSIONAL STATE 437
65 CREATININE RENAL CLEARANCE DECREASED 436
66 DIPLOPIA 435
67 SEDATION COMPLICATION 430
68 COUGH 428
69 MUSCLE TWITCHING 427
70 BLINDNESS 425
71 WEIGHT DECREASED 412
72 ABDOMINAL PAIN 411
73 HYPERTENSION 410
74 VENTRICULAR TACHYCARDIA 400
75 VASCULITIS 399
76 EYE PRURITUS 398
77 PERICARDITIS 398
78 FACIAL PAIN 396
79 ATRIAL TACHYCARDIA 391
80 ANOSMIA 389
81 PAIN OF SKIN 386
82 SUBARACHNOID HAEMORRHAGE 385
83 PRODUCT DOSE OMISSION ISSUE 384
84 TENSION HEADACHE 384
85 CARDIOSPASM 383
86 PRURITUS GENITAL 380
87 CAROTID ARTERY OCCLUSION 378
88 PALMOPLANTAR KERATODERMA 376
89 SLEEP TERROR 375
90 PRODUCT USE IN UNAPPROVED INDICATION 374
91 INTENTIONAL PRODUCT USE ISSUE 373
92 WEIGHT INCREASED 351
93 CONDITION AGGRAVATED 349
94 PARAESTHESIA 316
95 INFUSION SITE SWELLING 315
96 ACUTE KIDNEY INJURY 306
97 DECREASED APPETITE 304
98 MYALGIA 303
99 RASH PAPULAR 291
100 COMPLETED SUICIDE 287
101 JOINT SWELLING 286
102 TREMOR 282
103 OVERDOSE 273
104 ERYTHEMA 268
105 MUSCLE SPASMS 265
106 ILLNESS 264
107 DRUG ABUSE 262
108 GAIT DISTURBANCE 258
109 IMMUNISATION 258
110 HYPOAESTHESIA 243
111 DRUG HYPERSENSITIVITY 241
112 DEATH 240
113 CHEST DISCOMFORT 233
114 COMA 232
115 OEDEMA PERIPHERAL 230
116 ASTHMA 228
117 SUICIDAL IDEATION 226
118 HYPERSENSITIVITY 224
119 AGITATION 222
120 MUSCULOSKELETAL STIFFNESS 222
121 NASOPHARYNGITIS 221
122 URINARY TRACT INFECTION 221
123 INFUSION SITE HAEMORRHAGE 212
124 ANAEMIA 210
125 ADVERSE DRUG REACTION 206
126 CONTUSION 206
127 EYE PAIN 205
128 RHEUMATOID ARTHRITIS 204
129 VISION BLURRED 203
130 DRY MOUTH 202
131 SWELLING FACE 200
132 LOSS OF CONSCIOUSNESS 198
133 URTICARIA 195
134 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 194
135 DRUG INTOLERANCE 190
136 CEREBROVASCULAR ACCIDENT 187
137 FIBROMYALGIA 183
138 NECK PAIN 183
139 WHEEZING 183
140 INFECTION 182
141 INFLUENZA 182
142 SINUSITIS 177
143 PRODUCT USE ISSUE 176
144 SLEEP DISORDER 175
145 DYSPEPSIA 172
146 BRONCHITIS 168
147 GASTROOESOPHAGEAL REFLUX DISEASE 168
148 SEROTONIN SYNDROME 167
149 SYNCOPE 167
150 ABDOMINAL DISTENSION 164
151 SWELLING 161
152 SEIZURE 159
153 THERAPY NON-RESPONDER 158
154 NIGHTMARE 154
155 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 154
156 UPPER RESPIRATORY TRACT INFECTION 154
157 GASTROINTESTINAL DISORDER 153
158 SWOLLEN TONGUE 153
159 PAIN IN JAW 150
160 HYPONATRAEMIA 145
161 FLUSHING 144
162 DYSPNOEA EXERTIONAL 143
163 INFUSION SITE DISCHARGE 142
164 DEVICE ISSUE 140
165 INFUSION SITE INFECTION 138
166 RENAL FAILURE 136
167 BLOOD PRESSURE INCREASED 135
168 MUSCULOSKELETAL PAIN 135
169 HEPATIC CYTOLYSIS 134
170 INJECTION SITE PAIN 134
171 INTENTIONAL OVERDOSE 133
172 NEUROPATHY PERIPHERAL 133
173 ARTHRITIS 132
174 DEVICE DISLOCATION 131
175 MATERNAL EXPOSURE DURING PREGNANCY 131
176 DEPRESSED MOOD 130
177 OXYGEN SATURATION DECREASED 130
178 SUICIDE ATTEMPT 127
179 DEVICE INFUSION ISSUE 126
180 STRESS 126
181 VERTIGO 126
182 CARDIO-RESPIRATORY ARREST 121
183 CELLULITIS 120
184 DYSPHAGIA 120
185 HOT FLUSH 119
186 IMPAIRED WORK ABILITY 118
187 NEUTROPENIA 118
188 BURSITIS 116
189 NEURALGIA 116
190 OROPHARYNGEAL PAIN 116
191 THROMBOSIS 113
192 GENERAL PHYSICAL HEALTH DETERIORATION 112
193 HAEMOGLOBIN DECREASED 112
194 DERMATITIS CONTACT 111
195 DEVICE FAILURE 111
196 STOMATITIS 111
197 BURNING SENSATION 110
198 EYE IRRITATION 110
199 FLUID RETENTION 110
200 NEPHROLITHIASIS 110
201 OEDEMA 110
202 PRODUCTIVE COUGH 110
203 SPEECH DISORDER 110
204 CHILLS 109
205 INCORRECT DOSE ADMINISTERED 109
206 INFUSION SITE REACTION 109
207 LETHARGY 109
208 THROMBOCYTOPENIA 109
209 ANGINA PECTORIS 106
210 BLISTER 106
211 INFUSION SITE INDURATION 106
212 CORONARY ARTERY DISEASE 105
213 DISORIENTATION 105
214 EPISTAXIS 105
215 LUNG DISORDER 105
216 TREATMENT FAILURE 105
217 FOETAL EXPOSURE DURING PREGNANCY 104
218 RASH PRURITIC 104
219 DRY EYE 103
220 PHOTOPHOBIA 103
221 RHINORRHOEA 103
222 BLOOD CHOLESTEROL INCREASED 102
223 INFUSION SITE PRURITUS 102
224 NASAL CONGESTION 102
225 SEPSIS 102
226 URINARY RETENTION 102
227 ATRIAL FIBRILLATION 101
228 C-REACTIVE PROTEIN INCREASED 101
229 DEVICE OCCLUSION 101
230 ELECTROCARDIOGRAM QT PROLONGED 101
231 GASTROINTESTINAL HAEMORRHAGE 101
232 ANAPHYLACTIC REACTION 100
233 HYPERLIPIDAEMIA 99
234 OSTEOARTHRITIS 99
235 CARDIAC DISORDER 98
236 ECZEMA 98
237 HALLUCINATION, VISUAL 98
238 DIABETES MELLITUS 97
239 CARDIAC ARREST 96
240 CATARACT 96
241 HYPOKALAEMIA 96
242 THERAPEUTIC PRODUCT EFFECT DECREASED 95
243 CHRONIC KIDNEY DISEASE 94
244 FLANK PAIN 94
245 DEVICE USE ERROR 93
246 DELIRIUM 92
247 LIVER DISORDER 91
248 CYSTITIS 89
249 DYSARTHRIA 89
250 INFUSION SITE IRRITATION 89
251 PSORIASIS 89
252 AGGRESSION 88
253 ANTICHOLINERGIC SYNDROME 88
254 PULMONARY EMBOLISM 88
255 RESTLESS LEGS SYNDROME 88
256 INFLUENZA LIKE ILLNESS 87
257 INJURY 87
258 BRADYCARDIA 86
259 CARDIAC FAILURE CONGESTIVE 86
260 DEVICE MAINTENANCE ISSUE 86
261 HERPES ZOSTER 86
262 SEASONAL ALLERGY 86
263 DEVICE MALFUNCTION 85
264 MYDRIASIS 85
265 CONJUNCTIVITIS 84
266 FEELING JITTERY 84
267 RENAL IMPAIRMENT 84
268 BONE DENSITY DECREASED 83
269 DEVICE LEAKAGE 83
270 INFUSION SITE WARMTH 83
271 LOWER RESPIRATORY TRACT INFECTION 83
272 RESPIRATORY FAILURE 83
273 CARDIAC FAILURE 82
274 INFLAMMATION 81
275 RASH MACULO-PAPULAR 80
276 SLEEP APNOEA SYNDROME 80
277 OCULAR HYPERAEMIA 79
278 PSYCHOTIC DISORDER 79
279 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 78
280 FEELING HOT 77
281 ACCIDENTAL OVERDOSE 76
282 PANIC ATTACK 76
283 WHITE BLOOD CELL COUNT DECREASED 76
284 POOR QUALITY SLEEP 75
285 RESTLESSNESS 75
286 HYPOGLYCAEMIA 74
287 NEOPLASM MALIGNANT 74
288 POISONING DELIBERATE 74
289 THERAPEUTIC RESPONSE DECREASED 74
290 BLOOD PRESSURE DECREASED 73
291 HYPOXIA 73
292 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 73
293 ARTHROPATHY 72
294 CONTRAINDICATED PRODUCT ADMINISTERED 72
295 DRUG WITHDRAWAL SYNDROME 72
296 HAEMORRHAGE 72
297 IRRITABILITY 72
298 PNEUMONIA ASPIRATION 71
299 SKIN ULCER 71
300 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 70
301 INTERSTITIAL LUNG DISEASE 70
302 MOOD ALTERED 70
303 THERAPY PARTIAL RESPONDER 70
304 CHOLESTASIS 69
305 HOSPITALISATION 69
306 URINARY INCONTINENCE 69
307 DYSKINESIA 68
308 IMPAIRED QUALITY OF LIFE 68
309 INJECTION SITE ERYTHEMA 68
310 MULTIPLE SCLEROSIS RELAPSE 68
311 RHABDOMYOLYSIS 68
312 DEVICE DIFFICULT TO USE 67
313 DEVICE POWER SOURCE ISSUE 67
314 RENAL FUNCTION TEST ABNORMAL 67
315 APHASIA 66
316 ATELECTASIS 66
317 DISCOMFORT 66
318 FLATULENCE 66
319 JOINT EFFUSION 66
320 RASH ERYTHEMATOUS 66
321 TENDERNESS 66
322 ALANINE AMINOTRANSFERASE INCREASED 65
323 DEEP VEIN THROMBOSIS 65
324 MENTAL DISORDER 65
325 MOOD SWINGS 65
326 SKIN DISCOLOURATION 65
327 BONE PAIN 64
328 EMOTIONAL DISTRESS 64
329 GASTRITIS 64
330 MULTIPLE DRUG THERAPY 64
331 MULTIPLE SCLEROSIS 64
332 PULMONARY HYPERTENSION 64
333 PULMONARY OEDEMA 64
334 TENOSYNOVITIS 64
335 HYPERSOMNIA 63
336 LIMB DISCOMFORT 63
337 LIMB INJURY 63
338 SKIN DISORDER 63
339 TREATMENT NONCOMPLIANCE 63
340 PRODUCT ADMINISTRATION INTERRUPTED 62
341 DEVICE WIRELESS COMMUNICATION ISSUE 61
342 PREMATURE BABY 61
343 THROAT IRRITATION 61
344 CRYING 60
345 HAEMATOCHEZIA 60
346 HYPOTHYROIDISM 60
347 INFUSION RELATED REACTION 60
348 RASH MACULAR 60
349 ULCER 60
350 INFUSION SITE NODULE 59
351 PLATELET COUNT DECREASED 59
352 RENAL DISORDER 59
353 WITHDRAWAL SYNDROME 59
354 BLOOD CREATINE PHOSPHOKINASE INCREASED 58
355 FEMUR FRACTURE 58
356 INFUSION SITE BRUISING 58
357 MOVEMENT DISORDER 58
358 PURULENT DISCHARGE 58
359 FOETAL GROWTH RESTRICTION 57
360 IMPAIRED HEALING 57
361 PLEURAL EFFUSION 57
362 RENAL FAILURE ACUTE 57
363 CONVULSION 56
364 EPILEPSY 56
365 HALLUCINATIONS, MIXED 56
366 INTESTINAL OBSTRUCTION 56
367 MALIGNANT NEOPLASM PROGRESSION 56
368 DYSURIA 55
369 HEAD DISCOMFORT 55
370 HEPATIC ENZYME INCREASED 55
371 INFUSION SITE DISCOLOURATION 55
372 JOINT INJURY 55
373 MEDICATION ERROR 55
374 SKIN EXFOLIATION 55
375 SYNOVITIS 55
376 DRUG DEPENDENCE 54
377 EXPOSURE DURING PREGNANCY 54
378 INSURANCE ISSUE 54
379 IRRITABLE BOWEL SYNDROME 54
380 LEUKOPENIA 54
381 NERVOUSNESS 54
382 ROAD TRAFFIC ACCIDENT 54
383 ALTERED STATE OF CONSCIOUSNESS 53
384 ARRHYTHMIA 53
385 BLOOD POTASSIUM DECREASED 53
386 DYSPHONIA 53
387 INJECTION SITE PRURITUS 53
388 PURPURA 53
389 COLITIS 52
390 DYSGEUSIA 52
391 PLEURITIC PAIN 52
392 RED BLOOD CELL COUNT DECREASED 52
393 SYNOVIAL CYST 52
394 ADVERSE EVENT 51
395 BLOOD CREATININE INCREASED 51
396 CREPITATIONS 51
397 DYSTONIA 51
398 INTERVERTEBRAL DISC PROTRUSION 51
399 ORAL HERPES 51
400 THROAT TIGHTNESS 51
401 ANTINUCLEAR ANTIBODY POSITIVE 50
402 DEMENTIA 50
403 DISEASE PROGRESSION 50
404 NIGHT SWEATS 50
405 NODULE 50
406 ORAL PAIN 50
407 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 50
408 SURGERY 50
409 TENOSYNOVITIS STENOSANS 50
410 CYANOSIS 49
411 FEELING COLD 49
412 GLUCOSE TOLERANCE IMPAIRED 49
413 INCONTINENCE 49
414 RESPIRATION ABNORMAL 49
415 RESPIRATORY DEPRESSION 49
416 CUSHINGOID 48
417 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 48
418 EAR INFECTION 48
419 LIVER FUNCTION TEST ABNORMAL 48
420 OSTEOPOROSIS 48
421 PANCREATITIS 48
422 PULMONARY ARTERIAL HYPERTENSION 48
423 DERMATITIS ATOPIC 47
424 FEBRILE NEUTROPENIA 47
425 HEAD INJURY 47
426 PALLOR 47
427 SKIN BURNING SENSATION 47
428 TYPE 2 DIABETES MELLITUS 47
429 ABNORMAL BEHAVIOUR 46
430 HYPOACUSIS 46
431 MOUTH ULCERATION 46
432 PANCREATITIS ACUTE 46
433 PRODUCT QUALITY ISSUE 46
434 RHEUMATOID NODULE 46
435 PANCYTOPENIA 45
436 SCLERITIS 45
437 ACUTE MYOCARDIAL INFARCTION 44
438 APPETITE DISORDER 44
439 DEPRESSIVE SYMPTOM 44
440 MENTAL STATUS CHANGES 44
441 MYOCLONUS 44
442 SCIATICA 44
443 SOPOR 44
444 THERAPY INTERRUPTED 44
445 CHOLELITHIASIS 43
446 INFUSION SITE INFLAMMATION 43
447 LOW BIRTH WEIGHT BABY 43
448 PARALYSIS 43
449 POLLAKIURIA 43
450 PRESYNCOPE 43
451 SYSTEMIC LUPUS ERYTHEMATOSUS 43
452 BRAIN FOG 42
453 CIRCULATORY COLLAPSE 42
454 DRUG DOSE OMISSION 42
455 EYE SWELLING 42
456 GAIT INABILITY 42
457 HELICOBACTER INFECTION 42
458 INFUSION SITE DISCOMFORT 42
459 INJECTION SITE BRUISING 42
460 NERVOUS SYSTEM DISORDER 42
461 PHARYNGEAL OEDEMA 42
462 SCAR 42
463 SYNOVIAL FLUID ANALYSIS 42
464 VIRAL INFECTION 42
465 AGRANULOCYTOSIS 41
466 ASPARTATE AMINOTRANSFERASE INCREASED 41
467 CREATININE RENAL CLEARANCE INCREASED 41
468 DEVICE ALARM ISSUE 41
469 EMOTIONAL DISORDER 41
470 HYPERKALAEMIA 41
471 INFUSION SITE RASH 41
472 INHIBITORY DRUG INTERACTION 41
473 MUSCLE RIGIDITY 41
474 PSORIATIC ARTHROPATHY 41
475 SKIN LESION 41
476 UNINTENTIONAL MEDICAL DEVICE REMOVAL 41
477 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 40
478 INJECTION SITE SWELLING 40
479 MENTAL IMPAIRMENT 40
480 PRODUCT DOSE OMISSION IN ERROR 40
481 ANGER 39
482 BLOOD SODIUM DECREASED 39
483 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 39
484 HYPOKINESIA 39
485 JOINT RANGE OF MOTION DECREASED 39
486 MANIA 39
487 OSTEONECROSIS 39
488 PNEUMOTHORAX 39
489 RALES 39
490 RECTAL HAEMORRHAGE 39
491 RESPIRATORY TRACT INFECTION 39
492 SENSORY LOSS 39
493 STAPHYLOCOCCAL INFECTION 39
494 UNRESPONSIVE TO STIMULI 39
495 WHITE BLOOD CELL COUNT INCREASED 39
496 ACCIDENTAL EXPOSURE TO PRODUCT 38
497 BLOOD PRESSURE SYSTOLIC INCREASED 38
498 DELUSION 38
499 HEPATITIS 38
500 HYPOCALCAEMIA 38
501 METABOLIC ACIDOSIS 38
502 SACROILIITIS 38
503 SINUS TACHYCARDIA 38
504 SOMATIC SYMPTOM DISORDER 38
505 TOOTH DISORDER 38
506 BREAST PAIN 37
507 DEVICE PHYSICAL PROPERTY ISSUE 37
508 HYPERTHERMIA 37
509 HYPOAESTHESIA ORAL 37
510 INFECTION SUSCEPTIBILITY INCREASED 37
511 PERICARDIAL EFFUSION 37
512 BLOOD PRESSURE FLUCTUATION 36
513 BODY TINEA 36
514 DEAFNESS 36
515 FOETAL DISORDER 36
516 HEPATIC STEATOSIS 36
517 HYPERGLYCAEMIA 36
518 INCORRECT PRODUCT ADMINISTRATION DURATION 36
519 INTERNATIONAL NORMALISED RATIO INCREASED 36
520 QUALITY OF LIFE DECREASED 36
521 BREAST CANCER 35
522 CARPAL TUNNEL SYNDROME 35
523 COORDINATION ABNORMAL 35
524 DEVICE RELATED INFECTION 35
525 EYE DISORDER 35
526 FEELING OF BODY TEMPERATURE CHANGE 35
527 FUNGAL INFECTION 35
528 HEART RATE DECREASED 35
529 ILL-DEFINED DISORDER 35
530 INTENTIONAL SELF-INJURY 35
531 LYMPHADENOPATHY 35
532 MUSCULOSKELETAL CHEST PAIN 35
533 NEEDLE ISSUE 35
534 BACK DISORDER 34
535 CARDIOGENIC SHOCK 34
536 DERMATITIS ALLERGIC 34
537 DIVERTICULITIS 34
538 DIZZINESS POSTURAL 34
539 DRUG TOXICITY 34
540 GASTROENTERITIS 34
541 HAEMATEMESIS 34
542 HAEMOPTYSIS 34
543 INFUSION SITE MASS 34
544 JOINT STIFFNESS 34
545 MITRAL VALVE INCOMPETENCE 34
546 MOUTH SWELLING 34
547 MUSCLE DISORDER 34
548 PRODUCT AVAILABILITY ISSUE 34
549 PRODUCT SUBSTITUTION ISSUE 34
550 SINUS DISORDER 34
551 ACNE 33
552 ACUTE RESPIRATORY FAILURE 33
553 ASCITES 33
554 BLADDER DISORDER 33
555 FEELING OF DESPAIR 33
556 HAEMATOMA 33
557 HAEMOGLOBIN INCREASED 33
558 HYPERVOLAEMIA 33
559 LOCALISED INFECTION 33
560 MAJOR DEPRESSION 33
561 MENINGIOMA 33
562 NO ADVERSE EVENT 33
563 OLIGOHYDRAMNIOS 33
564 PHARYNGEAL SWELLING 33
565 PRODUCT LEAKAGE 33
566 ABDOMINAL PAIN LOWER 32
567 ABNORMAL DREAMS 32
568 ACUTE RESPIRATORY DISTRESS SYNDROME 32
569 ALLERGY TO CHEMICALS 32
570 FEAR 32
571 GASTRIC ULCER 32
572 HEART SOUNDS 32
573 HYPERTONIA 32
574 LIGAMENT SPRAIN 32
575 LIVER INJURY 32
576 POST-TRAUMATIC STRESS DISORDER 32
577 PROLONGED EXPIRATION 32
578 RIB FRACTURE 32
579 UNEVALUABLE EVENT 32
580 CROHN^S DISEASE 31
581 DEVICE CONNECTION ISSUE 31
582 DYSSTASIA 31
583 GASTROENTERITIS VIRAL 31
584 INTENTIONAL DOSE OMISSION 31
585 LYMPHOEDEMA 31
586 PRURITUS GENERALISED 31
587 TOOTH INFECTION 31
588 TRANSAMINASES INCREASED 31
589 WOUND 31
590 GASTRIC DISORDER 30
591 HAND DEFORMITY 30
592 HEPATOCELLULAR INJURY 30
593 HIATUS HERNIA 30
594 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 30
595 MELAENA 30
596 MUSCULOSKELETAL DISCOMFORT 30
597 NEUROLEPTIC MALIGNANT SYNDROME 30
598 ORAL MUCOSAL BLISTERING 30
599 PARANOIA 30
600 PHOTOSENSITIVITY REACTION 30
601 SKIN LACERATION 30
602 UPPER LIMB FRACTURE 30
603 BACTERIAL INFECTION 29
604 DEFORMITY 29
605 DEVICE INFORMATION OUTPUT ISSUE 29
606 DISEASE RECURRENCE 29
607 DROOLING 29
608 EMPHYSEMA 29
609 FACE OEDEMA 29
610 GLAUCOMA 29
611 GLOMERULAR FILTRATION RATE DECREASED 29
612 HALLUCINATION, AUDITORY 29
613 MICTURITION URGENCY 29
614 OSTEOPENIA 29
615 PAROSMIA 29
616 PRODUCT PRESCRIBING ERROR 29
617 PULMONARY TOXICITY 29
618 RESPIRATORY DISORDER 29
619 APATHY 28
620 BODY TEMPERATURE DECREASED 28
621 BODY TEMPERATURE INCREASED 28
622 DISSOCIATION 28
623 EAR PAIN 28
624 FEEDING DISORDER 28
625 GAMMA-GLUTAMYLTRANSFERASE INCREASED 28
626 GLOSSODYNIA 28
627 HAEMATURIA 28
628 HEPATIC FUNCTION ABNORMAL 28
629 HEREDITARY ANGIOEDEMA 28
630 IMPAIRED GASTRIC EMPTYING 28
631 INTERVERTEBRAL DISC DEGENERATION 28
632 MULTIPLE ALLERGIES 28
633 MUSCLE SPASTICITY 28
634 NEUTROPHIL COUNT DECREASED 28
635 NOCTURIA 28
636 PSYCHOMOTOR HYPERACTIVITY 28
637 PULMONARY MASS 28
638 ROTATOR CUFF SYNDROME 28
639 SEPTIC SHOCK 28
640 SKIN IRRITATION 28
641 SPINAL OSTEOARTHRITIS 28
642 TOOTHACHE 28
643 ACUTE PSYCHOSIS 27
644 DEREALISATION 27
645 DEVICE ADHESION ISSUE 27
646 FOOT FRACTURE 27
647 HYPERAESTHESIA 27
648 LACRIMATION INCREASED 27
649 OESOPHAGITIS 27
650 PERSONALITY CHANGE 27
651 PNEUMONITIS 27
652 RASH GENERALISED 27
653 RETCHING 27
654 ARTERIOSCLEROSIS 26
655 BRONCHOSPASM 26
656 CARDIOVASCULAR DISORDER 26
657 DERMATITIS BULLOUS 26
658 ELECTROLYTE IMBALANCE 26
659 INCREASED APPETITE 26
660 INJECTION SITE REACTION 26
661 LEUKOCYTOSIS 26
662 OBESITY 26
663 OSTEONECROSIS OF JAW 26
664 PERIPHERAL COLDNESS 26
665 PREMATURE LABOUR 26
666 PRODUCT ADMINISTRATION ERROR 26
667 RESPIRATORY ARREST 26
668 SPINAL PAIN 26
669 TENDONITIS 26
670 VASCULAR DEVICE INFECTION 26
671 WRIST FRACTURE 26
672 BLOOD GLUCOSE DECREASED 25
673 CANDIDA INFECTION 25
674 DRUG ERUPTION 25
675 ENCEPHALOPATHY 25
676 HYPOMAGNESAEMIA 25
677 LACTIC ACIDOSIS 25
678 MENSTRUAL DISORDER 25
679 MUCOSAL INFLAMMATION 25
680 NEUTROPENIA NEONATAL 25
681 OSTEOMYELITIS 25
682 RESPIRATORY TRACT CONGESTION 25
683 SHOCK 25
684 SINUS CONGESTION 25
685 THERAPEUTIC RESPONSE SHORTENED 25
686 THERAPEUTIC RESPONSE UNEXPECTED 25
687 ANGINA UNSTABLE 24
688 ANKLE FRACTURE 24
689 APPENDICITIS 24
690 BIPOLAR DISORDER 24
691 BLOOD PRESSURE ABNORMAL 24
692 BONE DISORDER 24
693 COGWHEEL RIGIDITY 24
694 DEVICE PLACEMENT ISSUE 24
695 DRUG-INDUCED LIVER INJURY 24
696 EATING DISORDER 24
697 EXPOSURE VIA SKIN CONTACT 24
698 GALLBLADDER DISORDER 24
699 GASTRIC PH DECREASED 24
700 GROIN PAIN 24
701 HEART RATE IRREGULAR 24
702 HYPERCHOLESTEROLAEMIA 24
703 HYPOTONIA 24
704 JAUNDICE 24
705 LIVER FUNCTION TEST INCREASED 24
706 MUSCLE TIGHTNESS 24
707 OCULAR DISCOMFORT 24
708 OESOPHAGEAL PAIN 24
709 PERIORBITAL OEDEMA 24
710 RHINITIS 24
711 SPINAL FRACTURE 24
712 SUDDEN DEATH 24
713 TOOTH ABSCESS 24
714 TORSADE DE POINTES 24
715 TUBULOINTERSTITIAL NEPHRITIS 24
716 ASPIRATION 23
717 ATAXIA 23
718 BACK INJURY 23
719 CATHETER SITE PAIN 23
720 CEREBRAL HAEMORRHAGE 23
721 CEREBRAL VENTRICLE DILATATION 23
722 CERVICAL VERTEBRAL FRACTURE 23
723 DRUG USE DISORDER 23
724 EXOPHTHALMOS 23
725 H1N1 INFLUENZA 23
726 HAEMATOCRIT DECREASED 23
727 HEPATIC FAILURE 23
728 HEPATOTOXICITY 23
729 HIP FRACTURE 23
730 HYPOPHAGIA 23
731 KIDNEY INFECTION 23
732 MUSCLE ATROPHY 23
733 POLYNEUROPATHY 23
734 POST PROCEDURAL COMPLICATION 23
735 PROTEINURIA 23
736 SCHIZOPHRENIA 23
737 VITAMIN D DEFICIENCY 23
738 ABASIA 22
739 ABNORMAL LOSS OF WEIGHT 22
740 BLOOD ALKALINE PHOSPHATASE INCREASED 22
741 BLOOD IRON DECREASED 22
742 BLOOD UREA INCREASED 22
743 COAGULOPATHY 22
744 DIABETIC KETOACIDOSIS 22
745 ENTHESOPATHY 22
746 ERECTILE DYSFUNCTION 22
747 HYPERREFLEXIA 22
748 LYMPHOCYTE COUNT DECREASED 22
749 MIXED LIVER INJURY 22
750 PARAESTHESIA ORAL 22
751 PHARYNGITIS 22
752 POOR VENOUS ACCESS 22
753 SLOW SPEECH 22
754 SPINAL DISORDER 22
755 THIRST 22
756 ACUTE CORONARY SYNDROME 21
757 ANKYLOSING SPONDYLITIS 21
758 APPLICATION SITE ERYTHEMA 21
759 CHOKING 21
760 CLOSTRIDIUM DIFFICILE INFECTION 21
761 CORONARY ARTERY OCCLUSION 21
762 DEVICE USE ISSUE 21
763 DISABILITY 21
764 ECONOMIC PROBLEM 21
765 END STAGE RENAL DISEASE 21
766 EXTRAPYRAMIDAL DISORDER 21
767 GASTROINTESTINAL PAIN 21
768 GENERALISED TONIC-CLONIC SEIZURE 21
769 HAEMORRHOIDS 21
770 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 21
771 INFUSION SITE INJURY 21
772 INTENTIONAL DRUG MISUSE 21
773 KNEE ARTHROPLASTY 21
774 MASS 21
775 MIGRAINE WITH AURA 21
776 MIOSIS 21
777 OESOPHAGEAL SPASM 21
778 ORAL DISCOMFORT 21
779 PERIODONTITIS 21
780 PREMATURE DELIVERY 21
781 PULMONARY FIBROSIS 21
782 PULMONARY THROMBOSIS 21
783 SPUTUM DISCOLOURED 21
784 UNDERDOSE 21
785 UVEITIS 21
786 VISUAL ACUITY REDUCED 21
787 AMENORRHOEA 20
788 APPLICATION SITE PAIN 20
789 BLOOD TEST ABNORMAL 20
790 CARDIOMEGALY 20
791 CEREBRAL INFARCTION 20
792 CHROMATURIA 20
793 DECREASED ACTIVITY 20
794 EXTRA DOSE ADMINISTERED 20
795 HEMIPARESIS 20
796 INFUSION SITE CELLULITIS 20
797 MUSCULOSKELETAL DISORDER 20
798 MYOCARDIAL ISCHAEMIA 20
799 OBSTRUCTIVE AIRWAYS DISORDER 20
800 PRODUCT DISTRIBUTION ISSUE 20
801 SKIN FISSURES 20
802 SKIN INFECTION 20
803 SUPRAVENTRICULAR TACHYCARDIA 20
804 THERAPEUTIC PRODUCT INEFFECTIVE 20
805 WRONG TECHNIQUE IN DRUG USAGE PROCESS 20
806 ABORTION SPONTANEOUS 19
807 ABSCESS 19
808 AFFECTIVE DISORDER 19
809 ANXIETY DISORDER 19
810 BENIGN PROSTATIC HYPERPLASIA 19
811 BRADYPHRENIA 19
812 BRAIN MALFORMATION 19
813 C-REACTIVE PROTEIN ABNORMAL 19
814 CATHETER SITE ERYTHEMA 19
815 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 19
816 DEPERSONALISATION/DEREALISATION DISORDER 19
817 DEVICE BREAKAGE 19
818 DEVICE KINK 19
819 DIABETIC NEUROPATHY 19
820 DIARRHOEA HAEMORRHAGIC 19
821 FULL BLOOD COUNT DECREASED 19
822 HEAVY MENSTRUAL BLEEDING 19
823 HERNIA 19
824 HYPERCALCAEMIA 19
825 INCORRECT DRUG ADMINISTRATION RATE 19
826 INFLAMMATORY BOWEL DISEASE 19
827 INJECTION SITE HAEMORRHAGE 19
828 IRON DEFICIENCY ANAEMIA 19
829 JAW FRACTURE 19
830 LOWER LIMB FRACTURE 19
831 MULTIPLE ORGAN DYSFUNCTION SYNDROME 19
832 NEUTROPHIL COUNT INCREASED 19
833 OXYGEN CONSUMPTION INCREASED 19
834 PANIC REACTION 19
835 RESPIRATORY ACIDOSIS 19
836 SNEEZING 19
837 TASTE DISORDER 19
838 WEIGHT FLUCTUATION 19
839 BEHAVIOUR DISORDER 18
840 BREAST CANCER FEMALE 18
841 CLUMSINESS 18
842 CLUSTER HEADACHE 18
843 COLITIS ULCERATIVE 18
844 DENTAL CARIES 18
845 DRUG EFFECT DECREASED 18
846 ERUCTATION 18
847 EYELID PTOSIS 18
848 FOOD ALLERGY 18
849 GASTROINTESTINAL INFECTION 18
850 GINGIVITIS 18
851 GOUT 18
852 GYNAECOMASTIA 18
853 INFUSION SITE VESICLES 18
854 INJECTION SITE MASS 18
855 LOCALISED OEDEMA 18
856 PANIC DISORDER 18
857 PARKINSON^S DISEASE 18
858 RENAL INJURY 18
859 SMALL INTESTINAL OBSTRUCTION 18
860 SUBSTANCE USE 18
861 TARDIVE DYSKINESIA 18
862 AGEUSIA 17
863 ALLERGIC SINUSITIS 17
864 ATRIOVENTRICULAR BLOCK COMPLETE 17
865 BLOOD DISORDER 17
866 BREAST SWELLING 17
867 BRUXISM 17
868 CARBON DIOXIDE DECREASED 17
869 CARDIOMYOPATHY 17
870 CEREBELLAR STROKE 17
871 CEREBRAL HYPOPERFUSION 17
872 CHOKING SENSATION 17
873 CHOLECYSTITIS 17
874 COLD SWEAT 17
875 COMPLICATION ASSOCIATED WITH DEVICE 17
876 DIABETES MELLITUS INADEQUATE CONTROL 17
877 DISORGANISED SPEECH 17
878 DRUG LEVEL INCREASED 17
879 ENERGY INCREASED 17
880 EYE MOVEMENT DISORDER 17
881 GASTRIC HAEMORRHAGE 17
882 HYPERTONIC BLADDER 17
883 IMMUNODEFICIENCY 17
884 INTERVERTEBRAL DISC DISORDER 17
885 IRON DEFICIENCY 17
886 LARYNGITIS 17
887 MALNUTRITION 17
888 MULTIPLE DRUG OVERDOSE 17
889 NEOPLASM PROGRESSION 17
890 ORAL CANDIDIASIS 17
891 PERIPHERAL VASCULAR DISORDER 17
892 PRESCRIBED OVERDOSE 17
893 SECRETION DISCHARGE 17
894 SOMNAMBULISM 17
895 SUBSTANCE ABUSE 17
896 SUBSTANCE USE DISORDER 17
897 TENSION 17
898 THYROID DISORDER 17
899 TOXIC EPIDERMAL NECROLYSIS 17
900 VENTRICULAR ARRHYTHMIA 17
901 WOUND INFECTION 17
902 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 17
903 AFFECT LABILITY 16
904 ASTHENOPIA 16
905 AUTOIMMUNE DISORDER 16
906 AUTOIMMUNE HEPATITIS 16
907 BLOOD URINE PRESENT 16
908 BONE MARROW FAILURE 16
909 CATHETER SITE HAEMORRHAGE 16
910 CHOLECYSTECTOMY 16
911 DERMATITIS 16
912 DERMATITIS PSORIASIFORM 16
913 DIVERTICULUM 16
914 DRUG EFFECT LESS THAN EXPECTED 16
915 EYE INJURY 16
916 GLYCOSYLATED HAEMOGLOBIN INCREASED 16
917 HEPATIC ENCEPHALOPATHY 16
918 HUNGER 16
919 INITIAL INSOMNIA 16
920 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 16
921 LIBIDO DECREASED 16
922 LIP PRURITUS 16
923 LIPIDS INCREASED 16
924 OVARIAN CYST 16
925 PROCEDURAL PAIN 16
926 PRODUCT ADHESION ISSUE 16
927 PRODUCT COMPLAINT 16
928 PRODUCT DOSE OMISSION 16
929 PYELONEPHRITIS 16
930 SKIN ABRASION 16
931 SKIN CANCER 16
932 SLEEP DEFICIT 16
933 SWELLING OF EYELID 16
934 SYNOVIAL DISORDER 16
935 TOOTH LOSS 16
936 TRICUSPID VALVE INCOMPETENCE 16
937 VENTRICULAR HYPERTROPHY 16
938 VITREOUS FLOATERS 16
939 ABDOMINAL TENDERNESS 15
940 APHONIA 15
941 APHTHOUS ULCER 15
942 BLOOD POTASSIUM INCREASED 15
943 BRADYKINESIA 15
944 BUNDLE BRANCH BLOCK RIGHT 15
945 CFTR GENE MUTATION 15
946 CORONARY ARTERY STENOSIS 15
947 COVID-19 PNEUMONIA 15
948 CYST 15
949 EOSINOPHILIA 15
950 FACET JOINT SYNDROME 15
951 FACIAL PARALYSIS 15
952 GASTRITIS EROSIVE 15
953 GENERAL PHYSICAL CONDITION ABNORMAL 15
954 GENERALISED OEDEMA 15
955 HYPOVENTILATION 15
956 INJECTION SITE RASH 15
957 INTERMENSTRUAL BLEEDING 15
958 LYMPHOPENIA 15
959 MUCOSAL DRYNESS 15
960 PANCREATITIS RELAPSING 15
961 PATIENT DISSATISFACTION WITH DEVICE 15
962 PELVIC PAIN 15
963 PHARYNGITIS STREPTOCOCCAL 15
964 PRE-EXISTING CONDITION IMPROVED 15
965 PRODUCT USE COMPLAINT 15
966 PULMONARY PAIN 15
967 RENAL INFARCT 15
968 RIGHT VENTRICULAR FAILURE 15
969 SECONDARY ADRENOCORTICAL INSUFFICIENCY 15
970 SKIN WARM 15
971 STAPHYLOCOCCAL SEPSIS 15
972 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 15
973 TENDON DISORDER 15
974 TOOTH FRACTURE 15
975 TRIGEMINAL NEURALGIA 15
976 VAGINAL HAEMORRHAGE 15
977 WRIST DEFORMITY 15
978 ABNORMAL WEIGHT GAIN 14
979 ACIDOSIS 14
980 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 14
981 ANAL INCONTINENCE 14
982 ANAPHYLACTIC SHOCK 14
983 ANHEDONIA 14
984 APNOEA 14
985 ATRIOVENTRICULAR BLOCK 14
986 BACTERAEMIA 14
987 BLEPHAROSPASM 14
988 BLOOD ALBUMIN DECREASED 14
989 BLOOD TRIGLYCERIDES INCREASED 14
990 BRAIN INJURY 14
991 CARBON DIOXIDE ABNORMAL 14
992 CEREBRAL ATROPHY 14
993 CEREBRAL ISCHAEMIA 14
994 COMMUNICATION DISORDER 14
995 DECREASED INTEREST 14
996 DIABETIC FOOT 14
997 DRUG ADMINISTRATION ERROR 14
998 DRUG TITRATION ERROR 14
999 DYSAESTHESIA 14